Contract development and manufacturing organization (CDMOs) for biopharma

The way forward in biologics manufacturing

The trend of outsourcing is increasing the thrust of contract development and manufacturing organizations (CDMOs) into the spotlight. There is a push towards engaging the services of CDMOs by emerging biotechnology groups which don’t have the resources to do development or manufacturing in-house; and, by larger biopharmaceutical companies which are facing capacity constraints and looking to quickly increase their current capacity. ​To meet these changing demands, it is critical for CDMOs to find ways to scale, and scale quickly, within their current footprint. At Thermo Fisher Scientific, we are able to offer a range of solutions from supporting CMDOs to serving as a CDMO.

Request information       Download flyer


Market dynamics impacting CDMOs
 

  

Prioritizing speed

  

Increasing complexity

  

Mitigating supply challenges

  

Evolving role in decision making process


Scale up efficiently and effectively
 


Reduce complexity in your bioprocess
 


Mitigate supply challenges and raw material shortages

The industry is facing supply shortage, and companies must mitigate supply challenges to ensure they are able to continue their critical work. Listen to a customer’s perspective on the significance of working with a reliable partner for redundancy of supply, timing, and quality.




Reduce complexity in your bioprocess
 

Bioprocessing resources

Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing: